Page 84 - MemoriaES-Eng

RESEARCH GROUPS

í

ñ
á

á

é

PROGRAMME:
Group 17
Tuberculosis* /

New Therapeutic Targets*

Group Members
Lead Researcher

STAFF MEMBERS
Ausina Ruiz, Vicente

Lacoma de la Torre, Alicia
Muoz Quinto, Aroa
Contact:
Vilaplana Massaguer, Cristina
Servicio de Microbiología. 2a Planta. Edificio Maternal.
Hospital Universitario Germans Trias i Pujol. ASSOCIATED MEMBERS

Carretera Canyet, 08916 Badalona, Barcelona. Cardona Iglesias, Pere Joan
Phone: (+34) 93 497 88 94 · E.mail: [email protected] Domnguez Benitez, Jos Antonio

Websites: http://www.gencat.cat/ics/germanstrias/web_micro/
Gil Snchez, Olga
http://unitatdetuberculosiexperimental.wordpress.com/
Guirado Cceres, Evelina

Latorre Moreno, Irene
Prat Aymerich, Cristina
Main lines of research
Ruiz Manzano, Juan

• Development and evaluation of new experimental animal models in tuber-

culosis.

• New approaches to the nature, diagnosis and treatment of latent tuber-
culosis.

• New vaccines against tuberculosis.

• Antituberculosis drugs: resistance, action and evaluation of new drugs.

• New diagnostic methods and molecular epidemiology of tuberculosis.

• New molecular approaches to epidemiological, pathogenic and diagnostic
13
of the respiratory infections caused by respiratory virus, Haemophilus in- 20
T
fluenzae and Mycoplasma pneumonia.
R
PO
• Characterization of intracellular life stage of Staphylococcus aureus. Invol- E
vement in treatment and outcome of staphylococcal infections.
L R
A
• Design and evaluation of a novel inpedimetric immunosensor for diagnosis NU
N
of sepsis of respiratory origin.
A
/
• Improving the diagnosis of bloodstream Infections: PCR coupled with mass ES
* Strategic project 2013-2015: New ER
research and innovation on tuberculosis: spectrometry.
B
basic research, prevention, drug regi- CI
mens and diagnosis.
• Multiplexed determination of pathogenic bacteria in sepsis by novel mag-
** Strategic project 2013-2015: Respi- neto-nanohollows immunoassays.
84
ratory infections: form mechanisms to

therapeutics